Prihlásiť sa Zaregistrujte sa zadarmo

Prevádzková marža spoločnosti Intercept Pharmaceuticals Inc

Aká je hodnota metriky Prevádzková marža spoločnosti Intercept Pharmaceuticals Inc?

Hodnota metriky Prevádzková marža spoločnosti Intercept Pharmaceuticals Inc je -19.31%

Aká je definícia metriky Prevádzková marža?



Prevádzková marža je pomer prevádzkových výnosov vydelený čistými predajmi a vyjadrený v percentách.

Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.

Prevádzková marža spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Intercept Pharmaceuticals Inc

Čomu sa venuje spoločnosť Intercept Pharmaceuticals Inc?

we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.

Firmy s metrikou prevádzková marža podobnou spoločnosti Intercept Pharmaceuticals Inc